Industry Newsoswell platformhealth insuranceoscar health
Oscar Health Reports Revenue Growth And Expansion
6.1
Relevance Score
On January 9, UBS upgraded Oscar Health (NYSE: OSCR) to Neutral and raised its price target to $17 from $12. In Q3 2025 Oscar reported 23% year-over-year revenue growth to about $3.0 billion and a medical-loss ratio of 88.5% (up 380 basis points). Management plans 2026 expansion into 20 states, new products like HelloMeno, and AI integration via Oswell.
